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 SECTION S-1:  SUPPORTING FIGURES REFERRED TO IN THE MAIN TEXT 
 
 
Figures S1-S3 given below should be viewed in conjunction with the main text as. For a more 








H} NMR spectra for (a) 13 [obtained in the presence of a large excess ( 3 eq) of 
MSA]; (b) 12 together 13 and 14 (observed as an average); (c) the same sample as in (b) the 




Figure S2. NMR spectra recorded during a VT HP-NMR study on the in solution behaviour of 9 at 
(a) R.T., (b) 40 °C, (c) 70 °C, (d) 100 °C, (e) 130 °C and (f) back at R.T. Conditions: N-








H} NMR spectra of (a) a mixture of N-
phenylacetamide, 9 and MSA in thf-d8 under H2 (10 bar) at R.T (b) 11 and (c) a mixture of 12, 13 
and 14.  
 
 SECTION S-2:  CRYSTALLOGRAPHIC DISCUSSION  
 
 
The crystal and molecular structures of complexes 11, 12 and two water coordinated analogues of 14 
and 15, [Ru(CH3SO3-κ
1
O)2(H2O)(triphos)] (19) and [Ru(OAc-κ
1
O)2(H2O)(triphos)] (20), were 
determined by single crystal X-ray-diffraction and are depicted in Figures S4–S7 (see main text for 
the compound numbering scheme). In all of the determined structures, the geometry about the Ru(II) 
centers are best described as distorted octahedral with the triphos ligands adopting the expected facial 
configuration. Complex 11 crystallises together with two molecules of dichloromethane as yellow 
prisms in the monoclinic spacegroup P21/c (Figure S4). For 11 the Ru(1)–O(1), Ru(1)–O(2) and Ru–P 
bond lengths are comparable to those reported for the related complex, [RuCl(OAc)(triphos)] [(Ru–
O)avg. 2.224 Å and (Ru–P)avg 2.278 Å].
1
 Similarly the Ru(1)–O(3) distance of 2.203(4) Å compares 
well that between the oxygen coordinated dimethylsulfoxide (DMSO) ligands and the metal centre in, 
fac-[Ru(triphos)(DMSO-κ1O)2(H2O)]CF3SO3 [2.215(4)Å and 2.190(4) Å].
2
 The small chelate angle of 
the acetato ligand [59.80(15)°] forces a distorted octahedral geometry, resulting in widening of the 
O(1)–Ru(1)–P(2) [105.73(11)°] and O(2)–Ru(1)–P(3) [109.63(11)°] angles. Furthermore, in order to 
minimise steric congestion the methanesulfonato ligand is bent away from the triphos phenyl rings to 
give an O(3)–Ru(1)–P(1) angle [171.97(10)°] which deviates significantly from the ideal linearity. 
12 




Figure S4 Molecular structure of 11 with thermal ellipsoids set at 50 % probability. Hydrogen 
atoms and solvent molecules are omitted for clarity. Selected bond lengths (Å) and angles(°): 
Ru(1)–O(1) 2.173(4), Ru(1)–O(2) 2.210(4), Ru(1)–O(3) 2.203(4), Ru(1)–P(1) 2.2519(15), Ru(1)–
P(2) 2.2731(15), Ru(1)–P(3) 2.2551(13), O(1)–Ru(1)–O(3) 80.83(14), O(1)–Ru(1)–O(2) 
59.80(15), O(3)–Ru(1)–O(2) 84.23(14), O(1)–Ru(1)–P(1) 91.50(11), O(3)–Ru(1)–P(1) 171.97(10), 
O(2)–Ru(1)–P(1)  89.85(11), O(1)–Ru(1)–P(3) 169.42(11), O(3)–Ru(1)–P(3) 99.20(11), O(2)–
Ru(1)–P(3) 109.63(11), P(1)–Ru(1)–P(3) 87.89(5), O(1)–Ru(1)–P(2) 105.73(11), O(3)–Ru(1)–P(2) 
95.00(11), O(2)–Ru(1)–P(2) 165.48(11), P(1)–Ru(1)–P(2) 89.37(6), P(3)–Ru(1)–P(2) 84.83(5). 
The methanesulfonato bridged dimer, 12, crystallises from dichloromethane, together with three 
dichloromethane molecules, as yellow prisms in the triclinic space group Pī. In the molecular 
structure of 12, the coordination sphere around each Ru(II) centre adopts a slightly distorted 
octahedral geometry. When viewed along the RuRu vector, the two triphos ligands approach an 
eclipsed conformation while the bridging sulfonato ligands are staggered with respect to the P-atoms 
(Figure S5). The average Ru–O bonding distance (2.187) of the bridging ligands is comparable to that 
of the monodentate methanesulfonato ligand to Ru in 11 [Ru(1)–O(3) 2.203(4)]. Similarly, no 
noteworthy differences exist between the Ru–P bond lengths of compound 11 and 12.   
During an attempt to separate 14 from a mixture of 12, 13 and 14 by recrystallisation, the water 
coordinated analogue [Ru(CH3SO3-κ
1
O)2(H2O)(triphos)] (19) crystallised from solution as yellow 
prisms in the monoclinic space group P2/n. Although the asymmetric unit contains two unique 
molecules of 19 co-crystallised with five solvent molecules, only one of them will be discussed here 
as no significant difference between their corresponding bond lengths and angles (Figure S6) exist. 
The methanesulfonato ligands are bent away from the triphos ligand towards the coordinated water 
molecule not only to minimise steric interactions but also to facilitate the formation of two six 
membered rings through hydrogen bonding, which aids in stabilising the structure. As for complex 11, 
the Ru(1)–O(1) [2.209(5) Å], Ru(1)-O(3) [2.207(5) Å] and the average Ru-P (2.273 Å) bonding 







Figure S5 Molecular structure of 12 with thermal ellipsoids set at 50 % probability. Hydrogen 
atoms and solvent molecules are omitted for clarity. Selected bond lengths (Å) and angles(°): 
Ru(1)–O(1) 2.167(6) Ru(1)–O(2) 2.195(6), Ru(1)–O(3) 2.190(6), Ru(2)–O(4) 2.181(7), Ru(2)–
O(5) 2.193(6), Ru(2)–O(6) 2.193(5), Ru(1)–P(1) 2.251(3), Ru(1)–P(2) 2.283(3), Ru(1)–P(3) 
2.263(3), Ru(2)–P(4) 2.279(2), Ru(2)–P(5) 2.252(3), Ru(2)–P(6) 2.280(3), O(1)–Ru(1)–O(2) 
83.5(3), O(1)–Ru(1)–O(3) 84.0(3), O(3)–Ru(1)–O(2) 81.9(3), O(1)–Ru(1)–P(1) 90.71(17), O(3)–
Ru(1)–P(1) 174.48(17), O(2)–Ru(1)–P(1)  95.88(17), O(1)–Ru(1)–P(3) 178.94(15), O(3)–Ru(1)–
P(3) 96.62(18), O(2)–Ru(1)–P(3) 95.79(19), P(1)–Ru(1)–P(3) 88.62(9), O(1)–Ru(1)–P(2) 
94.10(18), O(3)–Ru(1)–P(2) 93.59(17), O(2)–Ru(1)–P(2) 175.05(16), P(1)–Ru(1)–P(2) 88.44(9), 
P(3)–Ru(1)–P(2) 86.70(9), O(1)–S(1)–O(4) 112.5(4), O(2)–S(2)–O(5) 112.0(4), O(3)–S(3)–O(6) 
113.4(4). 
 
Figure S6 Molecular structure of 19 with thermal ellipsoids set at 50% probability. Included 
solvent molecules and hydrogen atoms (with the exception of those associated with water) are 
omitted for clarity. Selected bond lengths (Å) and angles(°):  Ru(1)–O(3) 2.207(5), Ru(1)–O(1) 
2.209(5), Ru(1)–O(2) 2.223(5), Ru(1)–P(3) 2.2615(19), Ru(1)–P(1) 2.2668(19), Ru(1)–P(2) 
2.2914(18), S(1)–O(1) 1.472(5), S(1)–O(1) 1.472(5), P(1)–C(3) 1.841(8), P(2)–C(4) 1.837(7), 
P(3)–C(5) 1.833(7), O(3)–Ru(1)–O(1) 82.43(19), O(1)–Ru(1)–O(2) 81.8(2), O(3)–Ru(1)–O(2) 
81.7(2), O(3)–Ru(1)–P(3) 95.71(15), O(1)–Ru(1)–P(3) 177.77(15), O(2)–Ru(1)–P(3) 96.77(17), 
O(3)–Ru(1)–P(1) 96.77(15), O(1)–Ru(1)–P(1) 94.92(15), O(2)–Ru(1)–P(1) 176.50(17), P(3)–
Ru(1)–P(1) 86.50(7), O(3)–Ru(1)–P(2) 174.13(15), O(1)–Ru(1)–P(2) 94.93(14), O(2)–Ru(1)–P(2) 
92.76(15), P(3)–Ru(1)–P(2) 86.81(7), P(1)–Ru(1)–P(2) 88.66(7). 
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Compound 20, crystallised from a dichloromethane solution of 15 in the monoclinic space group 
P21/n. The structure of 20 is analogous to that of 11 in that the two acetato ligands are again bent 
towards the coordinated water molecule to allow for stabilisation through hydrogen bonding (Figure 
S7). Not surprisingly, the Ru(1)–O(1) and Ru(1)–O(3) bond lengths [2.1614(15) Å and 2.1510(15) Å] 
are slightly shorter than those of the bidentate acetato ligand in 11 [2.167(4) (4) Å and 2.209(4) Å], 
where slight bond elongation is brought about by ring strain. Similar to complexes 11, 12 and 19, the 
constraints of the tridentate triphos ligand together with steric congestion around the Ru(II) centre 
causes all angles to deviate significantly from ideality with the largest divergence observed for the 
angle O(3)–Ru(1)–O(1) [80.86(6) °]. 
 
 
Figure S7 Molecular structure of 20 with thermal ellipsoids set at 50% probability. Hydrogen 
atoms (with the exception of those associated with water) are omitted for clarity. Selected bond 
lengths (Å) and angles(°): Ru(1)–O(1) 2.1614(15), Ru(1)–O(3) 2.1510(15), Ru(1)–O(5) 
2.1988(15), Ru(1)–P(1) 2.2844(6), Ru(1)–P(2) 2.2776(7), Ru(1)–P(3) 2.2647(6), O(3)–Ru(1)–O(1) 
80.86(6), O(3)–Ru(1)–O(5) 85.00(6), O(1)–Ru(1)–O(5) 86.63(6), O(3)–Ru(1)–P(3) 87.82(4), 
O(1)– Ru(1)–P(3) 87.58(4), O(5)–Ru(1)–P(3) 171.42(4), O(3)–Ru(1) –P(2) 95.07(4), O(1)–Ru(1)–
P(2) 175.80(4), O(5)–Ru(1)–P(2) 94.11(5), P(3)–Ru(1)–P(2) 91.21(2), O(3)–Ru(1)–P(1) 175.35(4), 





















 SECTION S-3:  ANALYTICAL DATA FOR AMIDE SUBSTRATES PREPARED IN HOUSE 
 
 
General procedure for the synthesis of amides 
A solution of the corresponding amine (22 mmol) and triethylamine (22 mmol) in dichloromethane 
(50 ml) was cooled to 0 °C with an ice bath. The appropriate acid chloride (22 mmol) was added 
dropwise to the mixture over a period of 10 min at 0 °C. The solution was then allowed to warm to 
room temperature and stirred overnight. The mixture was then washed with a 2 M solution of HCl (3 
 50 ml) and a saturate NaHCO3 solution (3  50 ml). The organic phase was subsequently dried over 
anhydrous MgSO3 and the solvent removed in vacuo to give the crude product. Amides were further 














H} NMR (CDCl3, 100 MHz): δ = 170.6 (C=O), 143.9 (C-N), 136.1 (C-C=O), 130.1 (CH), 129.2 
(CH), 129.1 (CH), 127.9 (CH), 127.5 (CH), 126.3 (CH); GCMS: 273, 180, 167, 105, 77, 51; 








H NMR (CDCl3, 500 MHz): δ = 7.71 (2H, d, 
3
JHH = 8.1 Hz, CH), 7.37 (4H, d, JHH = 4.4 Hz, CH), 
7.32 (1H, m, CH), 7.24 (2H, d, 
3
JHH = 7.9 Hz, CH), 6.47 (1H, s, NH), 4.65 (2H, d, JHH = 5.6 Hz, CH2), 




H} NMR (CDCl3, 75 MHz ): δ = 167.4 (C=O), 142.0 (CMe), 138.4 (CCH2), 
131.5 (CC=O), 129.3 (CH), 128.8 (CH), 127.9 (CH), 127.6 (CH), 127.0 (CH), 44.1 (CH2), 21.5 
(CH3); GCMS: 225, 119, 106, 91; Elemental analysis: Found: C, 79.65; N, 6.33; H, 6.62. Calc. for 
















H NMR (CDCl3, 400 MHz): δ = 7.33 (2H, m, CH), 7.27 (3H, m, CH), 5.88 (1H, s, NH), 4.42 (2H, d, 
2
JHH = 5.7 Hz, CH2), 2.01 (3H, s, CH3); 
1
H NMR ((CD3)2SO, 400 MHz): δ = 8.34 (1H, s, NH), 7.30 
(2H, m, CH), 7.22 (3H, m, CH), 4.24 (2H, d, 
2





((CD3)2SO, 100 MHz): δ = 169.1 (C=O), 139.5 (CCH2)), 128.2 (CH), 127.2 (CH), 126.7 (CH), 42.0 
(CH2), 22.5 (CH3);  Elemental analysis: Found: C, 72.88; N, 9.63; H 7.06,. Calc. for C9H11NO: C, 









H NMR (CDCl3, 300 MHz): δ = 7.81 (1H, s, NH), 7.77 (2H, d, 
3
JHH = 8.2 Hz, CH), 7.64 (2H, dd, 
3
JHH = 8.5, 
4
JHH = 1.0 Hz, CH), 7.37 (2H, t, JHH = 8.0 Hz, CH), 7.28 (2H, d, 
3
JHH = 7.9 Hz), 7.14 (1H, 
tt, 
3
JHH = 7.4, 
4
JHH = 1.1 Hz, CH), 2.43 (3H, s, CH3); 
1
H NMR ((CD3)2SO, 400 MHz): δ = 10.14 (1H, 
s, NH), 7.86 (2H, d, 
3
JHH = 8.2 Hz, CH), 7.76 (2H, d, 
3
JHH = 7.6 Hz, CH), 7.33 (4H, m, CH), 7.08 (1H, 
tt, 
3
JHH = 7.4 Hz, 
4




H} NMR ((CD3)2SO, 100 MHz): δ = 
165.3 (C=O), 141.5 (CMe), 139.2 (C-NH), 132.0 (C-C=O), 128.8 (CH), 128.5 (CH), 127.6 (CH), 







H NMR ((CD3)2CO, 300 MHz): δ = 10.09 (1H, s, NH), 7.97 (2H, dt, 
3
JHH = 9.8 Hz, 
4
JHH = 2.5 Hz, 
CH), 7.78 (2H, d, 
3
JHH = 7.5 Hz, CH), 7.34 (2H, t, 
3





H} NMR ((CD3)2CO, 100 MHz ): δ = 220.8 (C=O), 161.8 (C-OMe), 139.3 (C-N), 129.5 
(CH), 128.5 (CH), 126.9 (C-C=O), 123.4 (CH), 120.3 (CH), 113.5 (CH), 55.4 (CH3); Elemental 






 SECTION S-4:  GC-FID SPECTRA FOR THE POST RUN PRODUCT MIXTURES 
OBTAINED WITH SELECTED SUBSTRATES (LISTED IN TABLE S1). 
 
 































Primary amide [b]         
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1.5 200 10 100 61 
 
 








1.5 200 10 45 0 
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1.5 200 10 100 0 
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1.0 220 10 97 78 
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1.5 200 10 15 [f] <5 [f] 
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1.0 220 10 100 92 
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1.5 200 10 100 94 
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1.5 200 10 92 [c] 61 [c] 
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1.5 220 10 100 <5 
10 
 
1.5 200 10 75 75 
 








1.0 220 40 83 42 
20 
 




1.5 200 10 19 100 
21 
 




1.5 200 10 0 0 
[a] Conditions: Substrate (5 mmol), [Ru(acac)3] (1 mol %), triphos (2 mol %), thf (10 ml), 16 h. Conv. and Sel. 
calculated using NMR integration. [b] Reaction performed in the presence of NH3(aq) (10 ml). [c] Based on 
uncalibrated GC–FID integration. [d] Conv. 86%, Sel. 78% in Lit.5 [e] The Sel. for different reactions with N-
phenylacetamide under identical conditions varies between 86-92 %. In the presence of added mercury, 100% Conv. 


























































































 SECTION S-5:  EXAMPLE OF QUANTIFICATION BASED ON 1H NMR INTEGRATION 





 SECTION S-6:  CRYSTALLOGRAPHIC DATA TABLES 
 
 
Table S2. Crystallographic data for compounds 11 and 12. 
Parameter Compound 11 Compound 12 
   
Chemical formula C45H45O4P3Ru C86H90O12P6Ru2S4 
Formula weight (g/mol) 843.83 1831.87 
Temp. (K) 93(2) 93(2) 
Wavelength (Å) 0.71075 0.71075 
Crystal system Monoclinic Triclinic 
Crystal dimensions (mm
3
) 0.20  0.20  0.20 0.03  0.03  0.03 
Crystal shape and colour Prism, yellow Prism, yellow 
Space group P21/c (No. 14) P ī  (No. 2) 
a (Å) 10.057(2) 12.5217(5) 
b (Å) 15.075(3) 12.6970(5) 
c (Å) 29.442(6) 31.500(3) 
α () 90.0000 78.307(5) 
β () 96.663(5) 81.575(6) 
γ () 90.0000 68.302(5) 
Unit cell volume (Å
3
) 4433.7(15) 4542.6(5) 
No. of formula units per unit cell, Z 4 2 
dcalcd (g/cm
3
) 1.573 1.525 
Radiation type MoKα MoKα 
Absorption coefficient, μ (mm
-1
) 0.797 0.766 
F(000) 2152 2140 
-range for data collection () 2.04 to 25.35 3.06 to 25.41  
Index range 
-11 ≤ h ≤ 12, -18 ≤ k ≤ 14,  
 -33 ≤ l ≤ 35 
-10 ≤ h ≤ 10, -15 ≤ k ≤ 15, 
-37 ≤ l ≤ 37 
No. of reflections measured 26754 46062 
No. of unique reflections 8051 16487 
Refinement parameters / restraints 562 / 0 1078 / 18 
Rint 0.0943 0.0678 
Final R1 values (I > 2σ(I)) 0.0729 0.0864 
Final wR(F
2
) values (I > 2σ(I)) 0.2099 0.2241 
Final R1 values (all data) 0.0914 0.1126 
Final wR(F
2
) values (all data) 0.2393 0.2427 
Goodness of fit on F
2
 1.078 1.037 
Largest diff. peak and hole (e.A
-3
) 1.500 and -2.250 7.640 and -2.560 
Weighing scheme † 
a = 0.1406 
b = 8.3130 
a = 0.1063 
b = 70.0913 
   



















+bP+d+esinθ]; P = [f(Max(0 or Fo
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Table S3. Crystallographic data for compounds 19 and 20. 
Parameter Compound 19 Compound 20 
   
Chemical formula C43H47O7P3Ru C45H47O5P3Ru 
Formula weight (g/mol) 869.82 861.84 
Temp. (K) 93(2) 93(2) 
Wavelength (Å) 0.71075 0.71075 
Crystal system Monoclinic Monoclinic 
Crystal dimensions (mm
3
) 0.12  0.10  0.03 0.03  0.03  0.03 
Crystal shape and colour Prism, yellow Prism, yellow 
Space group P21/n (No. 14) P21/n (No. 14) 
a (Å) 12.702(2) 11.969(2) 
b (Å) 31.997(6) 20.106(4) 
c (Å) 24.329(5) 16.576(3) 
α () 90.00 90.00 
β () 100.330(2) 102.415(3) 
γ () 90.00 90.00 
Unit cell volume (Å
3
) 9727(3) 3895.6(12) 
No. of formula units per unit cell, Z 8 4 
dcalcd (g/cm
3
) 1.612 1.469 
Radiation type MoKα MoKα 
Absorption coefficient, μ (mm
-1
) 0.887 0.573 
F(000) 4824 1784 
-range for data collection () 1.70 to 25.42 1.62 to 25.35 
Index range 
-15 ≤ h ≤ 15, -38 ≤ k ≤ 38,  
 -29 ≤ l ≤ 29 
-14 ≤ h ≤ 14, -23 ≤ k ≤ 24, 
-19 ≤  l ≤ 19 
No. of reflections measured 97095 38423 
No. of unique reflections 17854 7119 
Refinement parameters / restraints 1159 / 4 498 / 0 
Rint 0.0621 0.0346 
Final R1 values (I > 2σ(I)) 0.0951 0.0299 
Final wR(F
2
) values (I > 2σ(I)) 0.2385 0.0622 
Final R1 values (all data) 0.0989 0.0315 
Final wR(F
2
) values (all data) 0.2413 0.0630 
Goodness of fit on F
2
 1.150 1.078 
Largest diff. peak and hole (e.A
-3
) 1.511 and -2.440 0.330 and -0.464 
Weighing scheme † 
a = 0.0973 
b = 93.0135 
a = 0.0193 
b = 4.8610 
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2










 SECTION S-7:  REFERENCES 
 
(1) Chaplin, A. B.; Dyson, P. J. Inorg. Chem. 2008, 47, 381. 
(2) Iengo, E.; Zangrando, E.; Baiutti, E.; Munini, F.; Alessio, E. Eur. J. Inorg. Chem. 2005, 1019. 
(3) Núñez Magro, A. A. PhD Thesis 2007, 244. 
(4) Wei, P.; Bi, X.; Wu, Z.; Xu, Z. Org. Lett. 2005, 7, 3199. 
(5) Stein, M.; Breit, B. Angew. Chem. Int. Ed. 2012, DOI: 10.1002/anie.201207803. 
 
 
